Skip to content
About Us
Mission and Vision
Strategic Priorities
Scientific Advisory Committee
Sponsors
Member Partners
Resources
Educational Modules
Educational Events
Other Resources
Publications
Communications
Press Releases
Contact Us
About Us
Mission and Vision
Strategic Priorities
Scientific Advisory Committee
Sponsors
Member Partners
Resources
Educational Modules
Educational Events
Other Resources
Publications
Communications
Press Releases
Contact Us
Posts on June 25, 2026
Press Release
Jun 25
/
admin
/
0
TRYNGOLZA® (olezarsen) aproved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
CARLSBAD, Calif.–(BUSINESS WIRE)–Jun. 24, 2026– Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA® […]
Read more
Search
Recent Posts
TRYNGOLZA® (olezarsen) aproved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis
Recognition and Management of Persistent Chylomicronemia
Recent Comments
No comments to show.
